Cargando…
Effectiveness of the golimumab educational program in ensuring healthcare professionals’ awareness of risks described in the European risk management plan
BACKGROUND: The golimumab safety awareness study commenced in 2010 to measure, periodically, the awareness of golimumab prescriber healthcare professionals (HCPs) of specific risks associated with golimumab as well as awareness of the requirement to provide a patient alert card to each patient treat...
Autores principales: | Felo, Lauren, Otero-Lobato, Marijo, Geldhof, Anja, Noël, Wim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535730/ https://www.ncbi.nlm.nih.gov/pubmed/31205675 http://dx.doi.org/10.1177/2042098619847420 |
Ejemplares similares
-
Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database
por: Ziyadeh, Najat J., et al.
Publicado: (2020) -
Risk Management Plans: reassessment of safety concerns based on Good Pharmacovigilance Practices Module V (Revision 2)—a company experience
por: Esslinger, Suzan, et al.
Publicado: (2022) -
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
por: Pugliese, Daniela, et al.
Publicado: (2016) -
Golimumab for Rheumatoid Arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019) -
Golimumab in unresponsive ulcerative colitis
por: Lippert, Elisabeth, et al.
Publicado: (2014)